|
THURSDAY, JUNE 30, 2016 |
|
2016 - Essentials for
Interpreting Oncologic Imaging Examinations |
Chair: D.M. Panicek, New
York/US |
|
08:30 | Welcome and Introduction |
| H. Hricak, New York/US / Ch. Herold, Vienna/AT |
08:35 | Key Elements in Oncologic Imaging Reporting |
| D.M. Panicek, New York/US |
08:55 | Cancer-specific Treatment Response Criteria |
| M.E. Mayerhöfer, Vienna/AT |
09:15 | Assessing Response to Treatment on PET/CT |
| C. Cyran, Munich/DE |
09:35 | Treatment Response Assessment: Challenges and Recommendations for
Lesion Measurement |
| D.M. Panicek, New York/US |
09:55 | Structured Oncologic Reporting: Current Initiatives and Future
Developments |
| W. Sommer, Munich/DE |
10:15 | Panel Discussion |
| Speakers |
10:45 | Coffee break |
|
Lung Cancer Screening and Diagnosis |
Chair: Ch. Herold, Vienna/AT |
|
11:10 | Screening - Pros and Cons |
| Ch. Herold, Vienna/AT |
11:30 | Present and Future Indications for MRI in Lung Malignancies |
| J. Dinkel, Munich/DE |
11:50 | New Classification of Lung Cancer Types |
| Ch. Herold, Vienna/AT |
12:10 | Panel Discussion |
| Speakers |
12:30 | Lunch Break (vouchers only) |
|
Hepatobiliary Imaging in
Oncology |
Chair: D. Regge, Torino/IT |
|
13:30 | Algorithmic Approach to Hepatic Lesions |
| W. Sommer, Munich/DE |
13:50 | Preoperative Planning for Hepatic Surgery: What the Surgeon Needs to
Know |
| D. Tamandl, Vienna/AT |
14:10 | Imaging of Cholangiocarcinoma |
| D. Regge, Torino/IT |
14:30 | Panel Discussion |
| Speakers |
14:50 | Coffee break |
|
Hot Topics/Emerging
Applications |
Chair: H. Hricak, New York/US |
|
15:20 | How to Prepare for MR/PET |
| J. Lewis, New York/US |
15:30 | High-field MR – Clinical Utilization: Myth or Reality? |
| S. Trattnig, Vienna/AT |
15:40 | Hyperpolarized 13C - Entering the Clinical Realm |
| K. Keshari, New York/US |
15:50 | Phase-contrast Radiography and CT |
| M.F. Reiser, Munich/DE |
16:00 | Radiomics in Oncology: The Next Frontier in Clinical Decision Making |
| H. Hricak, New York/US |
16:20 | MR/PET: Current Status and Potential Applications in Oncology |
| M.E. Mayerhöfer, Vienna/AT |
16:40 | Panel Discussion |
| Speakers |
|
FRIDAY, JULY 1, 2016 |
|
Oncologic Issues in the
Abdomen |
Chair: M.F. Reiser, Munich/DE |
|
08:30 | Small Bowel Obstruction in the Oncology Patient |
| M. Gollub, New York/US |
08:50 | Non-obstructive GI Complications in Oncology Patients |
| T. Mang, Vienna/AT |
09:10 | Interventional Management of Therapy Complications in Oncology
Patients |
| M.F. Reiser, Munich/DE |
09:30 | Imaging of Gastrointestinal Stromal Tumors (GIST) |
| D. Regge, Torino/IT |
09:50 | Panel Discussion |
| Speakers |
10:10 | Coffee break |
|
Tips and Pitfalls in GI
Imaging of Oncology Patients |
Chair: M. Gollub, New York/US |
|
10:40 | Imaging of GI Neuroendocrine Tumors |
| M. Gollub, New York/US |
11:00 | Virtual Colonoscopy |
| T. Mang, Vienna/AT |
11:20 | Rectal Cancer Assessment with MRI |
| M. Gollub, New York/US |
11:40 | Panel Discussion |
| Speakers |
12:00 | Lunch break |
|
GU Oncology |
Chair: D.J. Husband, London/UK |
|
13:30 | Key Elements for Staging of Renal Tumors before Laparoscopic Surgery |
| M. D'Anastasi, Munich/DE |
13:50 | Risk-adapted Prostate MRI Report for Newly-diagnosed Patients |
| A. Vargas, New York/US |
14:10 | Typical Mistakes in Prostate MRI Reporting - and How to Avoid Them |
| K. Thierfelder, Munich/DE |
14:30 | Imaging of the treated prostate: tips and tricks |
| A. Vargas, New York/US |
14:50 | Panel Discussion |
15:10 | Speakers |
| Coffee break |
|
GYN Oncology |
Chair: C. Cyran, Munich/DE |
|
15:40 | Algorithmic Approach to the Female Pelvic Mass |
| E.Sala, New York/US |
16:00 | Staging Ovarian Cancer: Providing a GPS to Management |
| H. Hricak, New York/US |
16:20 | Imaging of the Treated Pelvis: Pearls and Pitfalls |
| E.Sala, New York/US |
16:40 | Added value of PET/CT in Staging Gynecologic Malignancies |
| C. Cyran, Munich/DE |
17:00 | Panel Discussion |
| Speakers |
|
SATURDAY, JULY 2, 2016 |
|
Breast Imaging |
Chair: E. Morris, New York/US |
Chair: Th. Helbich, Vienna/AT |
|
08:30 | Screening Recommendations and Controversies |
| D.D. Dershaw, New York/US |
08:50 | Using Ultrasound in the Screening & Diagnostic Setting |
| B. Brkljacic, Zagreb/HR |
09:10 | Percutaneous Breast Biopsy and Tumor Ablation: Advances |
| M. Fuchsjäger, Graz/AT |
09:30 | Screening with New Modalities: DBT and CEDM |
| C.H. Lee, New York/US |
09:50 | High Risk Lesions: How to Manage |
| Th. Helbich, Vienna/AT |
10:10 | Coffee break |
10:40 | Breast MRI: State-of-the-Art Clinical Use |
| Th. Helbich, Vienna/AT |
11:00 | Evaluating Treatment Response: MRI and PET |
| E. Morris, New York/US |
11:20 | Mammographic Density: Is It
Important? |
| C.H. Lee, New York/US |
11:40 | How I Do It: Audits,
Benchmarks and Performance |
| D.D. Dershaw, New York/US |
12:00 | Lunch Break |
|
Workshop: Breast Imaging |
|
13:30-14:30 | Breast imaging: Challenging Cases |
| M. Fuchsjäger, Graz/AT |
| B. Brkljacic, Zagreb/HR |
|
Workshop: Pelvic MRI |
|
13:30-14:30 | Cases for Aces |
| A. Vargas, New York/US |
| C. Cyran, Munich/DE |
|
Workshop: Breast Imaging |
|
14:30-16:00 | Breast Imaging: Clinical Dilemmas |
| K. Pinker-Domenig, Vienna/AT |
|
Workshop: Criteria-Based
Reporting (RECIST) |
|
14:30-16:00 | M. D'Anastasi, Munich/DE |
| W. Kunz, Munich/DE |
| |